This trial is active, not recruiting.

Conditions substance abuse, hiv
Treatments computer-facilitated hiv intervention, attention control
Phase phase 1
Sponsor Treatment Research Institute
Collaborator National Institute on Drug Abuse (NIDA)
Start date September 2012
End date December 2016
Trial size 371 participants
Trial identifier NCT01481428, #1002, R01DA030257


This study will be the first to examine the efficacy of using a brief, computerized HIV risk reduction intervention in treatment courts.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking single blind (subject)
Primary purpose prevention
(Active Comparator)
attention control
Life skills training DVDs that match the duration of the anticipated experimental condition. The DVDs address topics such as positive listening skills, anger management, and stress reduction.
computer-facilitated hiv intervention
Individuals assigned to the experimental condition will complete the self-directed CARE HIV intervention during each of their first three sessions. The 20 minute intervention sessions involve several components including a brief risk assessment, review of identified risks, structured skill building videos, and the development of a risk prevention action plan. Because of the adaptive nature of the CARE program, the content of each session will be tailored to address the current risks of the participant. While the main focus of the intervention is on risk, individuals who report being HIV infected will receive a referral to treatment if they are not currently receiving medical care and their session will address, among other things, adherence to HIV care.

Primary Outcomes

Engagement in high risk behaviors
time frame: 15 month follow-up

Secondary Outcomes

Rate of HIV testing
time frame: 15 month follow-up
Condom Procurement
time frame: 15 month follow-up
Self-reported Condom Use
time frame: 15 month follow-up

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: 1. be at least 18 years of age; 2. be charged with a non-violent felony offense 3. have no more than two prior non-violent convictions or diversionary opportunities 4. be willing to participate in the treatment court program for at least 12 months 5. be in need of treatment for substance abuse or dependence as assessed by case management. Exclusion Criteria: - Elderly subjects and those with medical problems will be included in the research as long as they do not have any physical or psychiatric condition that would impede their ability to give competent consent to research participation or to understand the research instruments. - Those individuals who are intoxicated, cognitively impaired, or psychiatrically unstable when approached will not be included; however, such individuals may subsequently be included if the disqualifying condition subsides. - Spanish speaking only individuals. - Client remanded to jail or residential treatment facilities at the time of Treatment Court enrollment.

Additional Information

Official title Delivering HIV Risk Reduction Services in Treatment Court
Principal investigator David S Festinger, Ph.D.
Description Four hundred consenting treatment drug court participants will be randomly assigned to either an HIV intervention group (n = 200) or an attention control group. All clients will attend their regularly scheduled status hearings which are scheduled approximately every six weeks. Clients in the HIV intervention group will receive a brief computerized, self-administered HIV risk reduction intervention following each of their first three status hearings. Clients in the attention control condition will view a series of educational life-skill videos of matched length following each of their first three status hearings. The primary outcome will be engagement in high risk behaviors as measured by the Risk Assessment Battery (RAB). Secondary HIV-related outcomes will include: (1) rate of HIV testing, (2) condom procurement, and (3) self-reported condom use. Tertiary outcomes related to treatment court compliance will include: (1) drug court graduation, (2) urinalysis-confirmed drug abstinence, (3) case management attendance, and (4) satisfaction with case management. In addition, we will conduct preliminary cost and cost-effectiveness analyses on the delivery of the brief computerized HIV intervention. Assessments will be conducted at baseline and 9- and 15-months post admission.
Trial information was received from ClinicalTrials.gov and was last updated in April 2016.
Information provided to ClinicalTrials.gov by Treatment Research Institute.